Endocrine oncology

Stable Iodine Intake and Thyroid Screening Outcomes After the Fukushima Nuclear Disaster: An Observational Study

J Clin Endocrinol MetabPublished Observational study

Main finding · Screening results indicating need for detailed examinationResult — go to the resultOdds ratio 0.839 95% CI 0.393–1.8

Authors' conclusion

Stable iodine intake was not associated with thyroid ultrasound screening results, probably because of the low radiation doses following the FDNPP accident. Parenchymal heterogeneity and thyroid volume were similar, supporting the conclusion that the adverse effects of single-dose stable iodine are minimal.

Study context

Population
Children born April 1998–March 2011 in Miharu Town, Fukushima, Japan, where stable iodine intake was implemented during the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident; regional thyroid screening program1,952 age- and sex-matched
Participants
1,974 children
Exposure
Stable iodine intake vs no intake
  • Intaken = 1,095
  • Non-intaken = 879reference
Outcome
Thyroid ultrasound screening results indicating the need for a detailed examination
Methodological detailscoarsened exact matching for sex and age, logistic regression analysis
  • Coarsened exact matching for sex and age
  • Logistic regression analysis

Main finding

As reported in the abstract

Screening results indicating need for detailed examination

Odds ratio

0.839

95% CI 0.393–1.8

P = 0.647

Intakevs Non-intake
OR 0.839 (95% CI 0.393–1.8); P = 0.647

Observational data: associations, not effects.

Further findings

Thyroid volume and parenchymal heterogeneity

Volume and parenchymal heterogeneity were not different between groups

Original publication

Stable Iodine Intake and Thyroid Screening Outcomes After the Fukushima Nuclear Disaster: An Observational Study. J Clin Endocrinol Metab. Published 29 May 2025. doi:10.1210/clinem/dgaf312

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.